Jump to content

5-alpha reductase inhibitors - no risk of male breast cancer.


JimJimJimJim

Recommended Posts

Jim Marshall (not a doctor) said ...

Taking 5-alpha reductase inhibitors, like Proscar or Propecia (finasteride) and Avodart (dutasteride) does not increase the risk of breast cancer in men.

These drugs, sometimes used for male hair loss, and for shrinking the size of large prostates without cancer, are also used in prostate cancer prevention and treatment.  Despite a clear anti-prostate cancer effect, the use of these drugs is controversial, with some oncologists (Dr Snuffy Myers is one) in favour, and others concerned about their use. The FDA has issued a warning to be placed on every pack.

A fuller account of 5-alpha reductase inhibitors (not related to this ASCO paper) can be found on member Chuck's Maack's site (http://tinyurl.com/n8a3yxj). (Chuck is also not a doctor.)

 

... end Jim

 

5-alpha reductase inhibitors and risk of male breast cancer.

This abstract is only available for 24 hours for members to get an email.


After 24 hours the abstract will only be available through the link to the ASCO site below.

Caution
This extract was published in association with the American Society of Clinical Oncology 2013 annual conference. Though the research behind it may have been excellent, your doctor cannot yet give much weight to it for a number of reasons, including:

  • It is only an extract. The full paper may reveal information important for your treatment.
  • The study has not yet had peer review - with doctors and researchers scrutinising the study closely for mistakes and limitations after it is published in a professional journal.
  •  Your doctor may already be aware of a limitations of the findings because of their wider reading.

The link below is to a page or document that we do not control.
Parts of it may be wrong or misleading.
Check with your doctor if something interests you.
If it is temporarily or permanently unavailable, you may receive an error message.

 

Source URL: http://meetinglibrary.asco.org/content/110421-132

Link to comment
Share on other sites

Archived

This topic is now archived and is closed to further replies.

×
×
  • Create New...